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Strengths and limitations of this study
 ► Interviews explored participants’ attitudes towards 
the new National Cervical Screening Program, 
where there is currently little research.
 ► Individual interviews were conducted until theoreti-
cal data saturation and the interview template was 
piloted.
 ► Convenience and snowball sampling through a pri-
vate general practice may have led to inaccurate 
sample representation.
 ► Most participants were well- screened for cervical 
cancer, which may not be inclusive of high- risk 
groups.
 ► The study was completed in an outer regional cen-
tre and may not apply to the general Australian 
population.
AbStrACt
Objectives To investigate women’s understanding and 
attitudes towards the National Cervical Screening Program 
(NCSP) and to explore methods to improve screening 
participation.
Design Semi- structured face- to- face interviews were 
conducted through convenience and snowball sampling. 
Thematic analysis occurred using the interpretivist 
framework.
Setting A private general practice in North Queensland.
Participants Women between the ages of 18 and 74 who 
attended the general practice were eligible to participate. 
Fourteen women between 20 and 58 years old were 
interviewed.
results Participants were concerned that the new NCSP 
would miss cancer due to longer screening intervals 
and reliance on primary human papilloma virus (HPV) 
testing. They believed that young women are at increased 
risk of cervical cancer, due to perceived HPV vaccine 
ineffectiveness and parent objection to vaccination. Most 
participants were not agreeable to self- sampling and 
preferred their doctor to perform screening. Personal 
and practitioner beliefs influenced a woman’s screening 
participation. Personal factors include being healthy for 
themselves and their family, previous abnormal smears 
and family history of cancer. Emphasis was placed 
on feeling ‘comfortable’ with their practitioner which 
included patient rapport and gender preference. Proposed 
methods to improve cervical screening included education 
programmes, advertising campaigns, general practitioner 
interventions and improving accessibility.
Conclusions It is apparent that women are hesitant about 
the new NCSP. However, when provided with additional 
information they were more amenable to the changes. 
This highlights the need to improve awareness of cervical 
screening and the new NCSP.
bACkgrOunD
While the National Cervical Screening 
Program (NCSP) has more than halved 
cervical cancer mortality, only 54%–56% of 
eligible Australian women1 participated in 
screening between January 2016 and June 
2017. This is especially concerning as over 
90% of women diagnosed with cervical cancer 
were under- screened or never- screened.2 
Women from lower socioeconomic status, 
rural areas or those that identify as Aborig-
inal and Torres Strait Islander have lower 
screening participation rates and higher 
cervical cancer mortality.1 Recently, the NCSP 
has been changed and has moved away from 
traditional pap smears, towards a 5 yearly 
cervical screening test (CST) for human 
papilloma virus (HPV) with reflex cytology.2 
Australian women begin cervical screening at 
25 years old and have an exit CST from 70 to 
74 years old. Women over 30 years who have 
never been or are currently under- screened 
are also eligible for self- sampling, consisting 
of a high vaginal swab for HPV.2 3
As per the WHO guidelines, there has 
been a global shift to HPV- based cervical 
screening.4 Worldwide, countries including 
the UK, Ireland, Netherlands and Turkey 
have implemented national HPV- based 
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cervical screening, with many more transitioning towards 
primary HPV testing.5 6 Previous international studies 
stated most women are unaware of the use of primary 
HPV testing7 and that some women may experience 
a negative emotional response towards primary HPV 
testing as it is a sexually transmitted infection.8 9 Due 
to the recent nature of changes to cervical screening, 
there is limited qualitative literature assessing Australian 
women’s attitudes towards the new NCSP. One Australian 
study used thematic analysis of an online petition against 
the new NCSP, revealing that the greatest concerns were 
missing cancer due to prolonged screening intervals and 
the delay in screening age.10
The researchers’ primary aim is to explore North 
Queensland women’s awareness and perceptions of the 
new NCSP. Knowledge of cervical cancer, factors that 
affect screening participation and methods to improve 
screening awareness were also investigated.
MethODS
Authors followed the Consolidated Criteria for Reporting 
Qualitative Health Research (COREQ).
Patient selection and setting
Women between 18 and 74 years old who attended a 
specific North Queensland general practice were eligible 
for this study with convenience and snowball sampling. 
This project was conducted with a concurrent quantita-
tive survey. Receptionists provided waiting room surveys 
and an expression of interest form for a follow- up inter-
view. Quantitative results collected through waiting room 
surveys will be published separately. The interviews were 
advertised on the practice’s Facebook page and partici-
pants were encouraged to promote the study to their 
family and friends. Women who expressed interest were 
contacted by phone or email.
Data collection
A semi- structured, face- to- face individual interview was 
conducted at the participant’s convenience at their home 
or a hospital meeting room between March and April 
2019. The average length of the interview was 20 min. 
All interviews were conducted by the primary author, a 
female medical student (AN) with training in qualitative 
research. The interviewer (AN) may have some personal 
bias as she is eligible for cervical screening. No partici-
pants were known to AN and participants were aware that 
this interview was part of an Honours project.
The piloted interview guide included questions about 
knowledge of cervical cancer and screening, opinions 
regarding the NCSP, barriers to screening and thoughts 
to improve screening participation. During the interview, 
participants were asked their opinions of the new NCSP, 
both with their baseline knowledge and after the inter-
viewer provided basic information on the programme. 
Additionally, the interviewer determined screening status 
in the interview. Screening status was defined using the 
previous guidelines due to the current transition to the 
new NCSP. A ‘well- screened’ participant had undergone 
cervical screening in the last 2 years while, an ‘under- 
screened’ participant was overdue for screening.
The interview guide (online supplementary appendix 
1) was developed after analysis of the existing liter-
ature11 12 and discussion among the investigators, 
including a general practitioner and a research officer, 
both experienced in qualitative research. Prior to the 
interview, participants signed a consent form for the 
interview to be audio- recorded. The interviews were tran-
scribed verbatim, including notes on non- verbal cues and 
were uploaded to NVivo. Transcribed interviews were not 
returned to participants for comments as there was no 
ambiguity that required clarification. Further, some meth-
odological literature suggests it may provide little benefit 
to improving data accuracy and it may lead to misrepre-
sentation of the original data.13 No repeat interviews were 
conducted. Data collection continued until theoretical 
data saturation was achieved.
Patient and public involvement
No participants were involved with the development of 
this study protocol or data analysis.
Data analysis
Transcribed interviews were analysed using NVivo V.1214 
using thematic analysis and the interpretivist paradigm. 
Data was analysed under relevant headings, for example 
‘Attitudes towards NCSP’ and ‘Factors affecting screening 
participation’ but no themes were predetermined. AN 
completed line- by- line coding to identify the preliminary 
themes and codes in the data, which were validated by 
another author (JB) with no significant changes to coding 
required. Data was further analysed to cluster themes under 
the appropriate research questions to create a thematic 
schema.
reSultS
Participant characteristics
Twenty- eight women expressed interest to be interviewed 
and were contacted by phone or email. Fourteen women 
consented to be interviewed, with four participants identi-
fied by convenience sampling and ten by snowball recruit-
ment. Table 1 displays individual participant characteristics. 
The age of participants ranged between 20 and 58 years 
old. Most women participated in screening and only two 
were considered under- screened as per the previous NCSP.
themes
Thematic analysis revealed three major themes on partic-
ipant’s attitudes towards the NCSP: ‘fear of missing 
cancer’, ‘younger women are at greater risk’, ‘self- 
sampling’ and ‘change is good’. Screening beliefs were 
subdivided into personal and practitioner factors. Based 
on participants’ suggestions, four potential intervention 
strategies emerged. Table 2 displays illustrative quotes for 
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Table 1 Demographic tables
Participant
Age 
(years) Screening status*
P1 41 Well- screened
P2 42 Under- screened
P3 43 Well- screened
P4 53 Well- screened
P5 30 Well- screened
P6 55 Well- screened
P7 58 Well- screened
P8 33 Well- screened
P9 20 Well- screened
P10 22 Well- screened
P11 57 Well- screened
P12 36 Well- screened
P13 38 Well- screened
P14 35 Under- screened
*Participants were considered well- screened if they had not 
participated in screening the last 2 years. Under- screened 
participants had not been screened in over 2 years or had never 
been screened.
these themes. A thematic schema depicting conceptual 
links throughout the themes is displayed in figure 1.
knowledge of cervical cancer and nCSP
Participants identified genetics and infection as the main 
causes of cervical cancer. Most participants did not specify 
HPV as the main cause of cervical cancer but when asked, 
participants were frequently aware of the link between HPV 
and cervical cancer. Hormones, contraceptive pill, smoking 
and toxins were listed by participants as causes of cervical 
cancer. Women considered family history and sexual 
activity as the main risk factors for cervical cancer. Other 
risk factors included not participating in regular screening, 
previous abnormal smears and being unvaccinated. Partici-
pants believed abnormal bleeding and pain were symptoms 
of cervical cancer though, many women were unsure of the 
symptoms. Bloating, abnormal discharge and pain during 
sex (dyspareunia) were also reported by some participants 
as symptoms of cervical cancer.
Participants understood that cervical screening occurs 
using pap smears and often could describe that pap smears 
look for abnormal cells. Some participants were aware of 
the change to screening and could correctly identify that 
screening now occurs 5- yearly. Women stated that cervical 
screening should occur in their early twenties and some 
said that it began with the onset of sexual activity.
Attitudes towards the new nCSP
Fear of missing cancer
Participants were anxious that 5 years was ‘a long time 
for cancer to grow’ (P12) and may lead to more women 
diagnosed with cancer. More regular screening was iden-
tified as having ‘a better chance of picking something up’ 
(P14) as ‘things in our body change very quickly’ (P1). 
There were fears that increased screening intervals may 
miss cancer, as clinicians may not always get a ‘clear swab’ 
(P8) and hence more regular screening was preferable. 
Additionally, participants were apprehensive that primary 
HPV testing would miss cancer caused by ‘things other 
than HPV’ (P9). They were uncomfortable with the CST 
not testing for abnormal cells as ‘I could be that one 
percent’ (P12) with cervical cancer not caused by HPV. 
Subsequently, some participants preferred cotesting for 
both HPV and abnormal cells to receive the benefits of 
both screening methods.
Women believed that ‘every 2 years is easy enough to 
recall but not 5 years’ (P12) and may not remember to 
participate in screening, due to increased screening inter-
vals. Participants were concerned that increased screening 
intervals will make women more ‘complacent’ (P12) in 
their screening behaviour and will delay screening even 
longer. They proposed that increased intervals required 
a register to provide appropriate reminders to women. A 
participant stated that increased intervals may also affect 
the feasibility of contacting patients, as after 5 years ‘not 
everyone lives at the same address’ (P7).
Those with a history of previous abnormal smears 
thought 5 yearly screening was ‘a little bit concerning’ 
(P8). Participants who had family or friends with cervical 
cancer were concerned by the increased screening interval 
as ‘they didn’t pick up hers until it was too late’ (P4). One 
participant negatively viewed delaying screening until 
a woman is 25 years, as her friend was diagnosed with 
cervical cancer earlier than this, and ‘if they didn’t catch 
it early, she’d be dead’ (P2). These personal experiences 
with abnormal smears or cervical cancer made women 
more ‘paranoid’ (P4) about cervical cancer.
Young women are at greater risk
Participants perceived that commencing screening from 
25 years old, placed women at increased risk for cancer 
due to earlier sexual activity of young women. Partici-
pants stated that children are ‘having sex a lot younger 
nowadays’ (P13). They highlighted that as young women 
are sexually active from their early teens, it may be ‘over 
10 years that kids are sexually active before they have 
screening’ (P3). Participants also believed that delaying 
cervical screening would prevent opportunistic testing 
for sexually transmitted infections in young women.
While some women identified that the introduction of 
the Gardasil vaccination was beneficial in reducing cervical 
cancer incidence, there was also a perception that ‘a lot 
of parents won’t let their kids have that’ (P5). This raised 
concerns as to whether unvaccinated women would be 
protected under the new NCSP in the future. Additionally, 
participants feared that ‘even though you are vaccinated 
you can still get diseases’ (P7) and believed that delaying 
screening will lead to cervical cancer being missed in 
women under 25 years. Some participants thought that 
patients diagnosed with cancer are becoming ‘younger 
and younger’ (P2). Younger women were described to be 
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Table 2 Themes and illustrative quotes
Theme
Attitudes to NCSP
  Fear of missing cancer
   A woman’s body 
changes quickly
So obviously, it’s important to try and catch it early and a couple of years can make a huge 
difference. So, I think it probably would have been better if they left it the way that it was. (P10)
But like stretching it out that bit further, it worries me that is something going to happen and by 
the time they come around to screening again, is it going to be too late for me? (P4)
   Missing non- HPV cancer If we miss that 1%, what’s that out of 100? That’s still one person. One person out of every 
hundred we’re missing, that’s sad. That’s someone’s mother, someone’s daughter. (P12)
I would think put some women at risk, that are not exposed to HPV and would get it otherwise. 
(P2)
   Women will forget And then it will get to that 5 years and people will still go, ‘Well I’ll just wait another 6 months.’ 
(P5)
I think there will be too many people that get complacent and I think because of it too many 
people will get sick. (P12)
   Personal experiences Considering that I’ve had smears that have been not… a little bit concerning, I’d be concerned 
about that. (P8)
A friend of mine got cervical cancer when she was 21… If they didn’t catch it early, she’d be 
dead. (P2)
  Younger women are at greater risk
   Earlier sexual activity A lot of children are starting to have sex at 13,14. At 25, for some kids that’s over 10 years that 
kids are sexually active before they have screening. (P3)
   Vaccine effectiveness Depends on how good the vaccination is and the stats around how effective that is. Because we 
know that vaccinations aren’t 100%. (P8)
Maybe that’s what contributed to the 25 age testing that a lot of younger women have had the 
Gardasil vaccine but even then, a lot of parents won’t let their kids have that. (P5)
   More young people have 
cancer
And I’ve heard that there has been cases of younger ones getting cervical cancer. Stuff that 
normally you don’t see til you are older and now coming up in younger women. (P4)
I think younger people are at higher risk. (P2)
  The changes are good
   Trust in medicine I think I’ve got faith in the doctors because there must be a reason as to why they are doing that. 
(P11)
   Reduced discomfort Well I like the idea of not having to go back every 2 years and not be in that uncomfortable 
position. (P14)
   Earlier detection of 
cancer
I guess it starts somewhere doesn’t it. If they pick up one thing, they can prevent it from leading 
to something else. (P13)
Screening beliefs
  Personal   
   To be healthy Just because I want to be healthy, like I go to the dentist and have a normal check- up every 
year. This is part of the routine. (P11)
   To be there for family It wouldn’t just affect me, it would affect my whole family. I couldn’t be selfish like that, to not 
get it done for whatever reason. Because, once you’re gone… you’ve left and not destroyed but 
you’ve upset your whole family by not going to look after yourself when it’s just a simple test. 
(P4)
   Hx cancer/abnormal 
smears
My grandma got really sick with cancer and so it kind of has impacted me to make sure I try and 
look after myself. (P10)
A long time ago I did have an abnormal smear. So, I guess knowing that, not wanting to go 
through that again making sure I’m keeping on top of that, so it doesn’t happen again. (P13)
  Practitioner   
   Feeling comfortable As long as I felt comfortable with the doctor. Their bedside manner was nice, they were clean, 
the instruments they used was sterile, they followed all their proper PPE precautions. (P12)
   Trust in regular GP I always just go to my GP. (P9)
…. because I had been going to him for a long time. (P4)
Continued
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Theme
   Male practitioner I just feel more comfortable with a female because I’m female (P11)
Potential interventions
  Education programme And that the girls should be learning about it at school in their health and wellness classes as 
well so that as maturing adults they are aware of what is going on in their own bodies. (P3)
Kids these days get information from their friends, if their parents don’t talk to them about it. 
So, if you are one of those parents that doesn’t, your children are going to take information from 
their friends that might be incorrect. (P5)
  General practitioner The GP would be good. You listen to them. Even if they give you a piece of paper, you go read 
that. (P6)
I do think that it would be a good idea that when you are having a pap smear the doctor talks to 
you about the relationship between cervical cancer and other issues and stuff (P3)
  Media campaign So just put it on my Facebook screen or my Instagram or something like that. So then, y’know 
that I can click on it and it’s private. (P2)
It’s something that should be spoken about more, y’know. And I just think advertising on tv 
would be a strong starting point (P12)
I feel like people need to hear about the stories of people actually having cancer. I think the 
scare factor is pretty effective for young people. (P8)
  Improving cost and 
accessibility
I think anything to do with those tests (cervical screening) should come with a bulk billing visit 
for women because it is a deterrent for going to your GP. (P5)
And if you did like pop up clinics because you know they always have pop up Red Cross Blood 
Van (P9)
Table 2 Continued
Figure 1 Relationship between identified themes.
at ‘higher risk’ (P2) of cervical cancer and participants 
felt that earlier detection of cervical cancer in women 
would improve their survival rates.
Change is good
Several participants expressed their ‘faith in the 
doctors’ (P11) and believed that screening would not 
have changed without underlying improvements in 
science. They perceived that ‘testing is that good’ (P7) 
if screening intervals have increased from every 2 years 
to 5 years. Participants highlighted that HPV testing is a 
positive change as it would ‘catch it (HPV)’ (P11) before 
abnormal cells became detectable by a traditional pap 
smear. They accepted that if HPV was ‘linked so strongly’ 
(P9) with cervical cancer, primary HPV testing was a 
beneficial change to cervical screening. After partici-
pants were provided information on the new NCSP and 
cervical cancer’s slow progression, they were more recep-
tive towards the new guidelines. An additional benefit of 
the new NCSP was that reduced screening would ‘make 
life easier’ (P6) for women, as cervical screening was 
described as ‘uncomfortable’ (P14) by participants.
Self-sampling
Participants were generally hesitant to accept self- 
sampling as they did not ‘feel confident enough in myself’ 
(P14) to administer the test. This stemmed from the fear 
of incorrectly completing the test as they may not ‘swab 
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far enough’ (P5) or that ‘it might be contaminated’ (P4). 
Doctors were thought to be better equipped to perform 
cervical screening as they had appropriate training to 
ensure it was ‘done properly’ (P8). It was perceived that 
doctors had better visualisation of the cervix as they used 
a speculum and would take a sample from ‘the right 
places’ (P3).
Nonetheless, participants acknowledged that self- 
sampling would provide women ‘more privacy’ (P10) 
and could improve screening participation. The test was 
deemed to be ‘less invasive’ (P5) than traditional cervical 
screening, especially for those who have had previous 
negative experiences with cervical screening. Participants 
often had the misconception that self- sampling required a 
cervical swab. When informed it was in fact, a high- vaginal 
swab more participants reported they would consider self- 
sampling. Some participants indicated that they would 
complete self- sampling if they were provided instructions 
or shown by a practitioner. Women highlighted that tech-
nological improvements allowed for ‘smaller traces’ (P2) 
of HPV to be detected and this made self- sampling more 
acceptable.
Factors affecting screening participation
Personal
Participants explained that cervical screening was a part 
of their normal health ‘routine’ (P11). Screening allowed 
them to have ‘peace of mind’ that they were healthy, and 
it allowed them to receive ‘further help’ (P1) if required. 
Many women emphasised that their family was the key 
reason they had cervical screening. They described their 
sense of responsibility to their family who required them 
to ‘make the right choices’ (P3) by undergoing screening. 
Participants disclosed that cancer could destroy their 
families and thus they chose to screen. A woman’s 
personal experiences with cancer shaped her willingness 
to participate in cervical screening. A history of abnormal 
smears motivated women to ‘keep on top’ (P13) of 
their screening to prevent reoccurrence. Women with a 
family history of cancer had firsthand experience as to 
how it devastated their families, which motivated them to 
undergo regular cervical screening.
Practitioner
Several participants described feeling ‘comfortable’ (P10) 
with their general practitioner as a facilitator to screening 
participation. This feeling of being ‘comfortable’ was 
influenced by the doctor’s bedside manner, professional 
behaviour and hygienic technique throughout the proce-
dure. Some women expressed that they trusted their 
regular doctor due to their pre- existing relationship, as 
they have known them for a ‘long time’ (P4). Participants 
frequently mentioned their practitioner’s gender when 
discussing screening participation. Most participants 
indicated that they are more ‘comfortable’ with a female 
doctor as she ‘has the same bits’ (P2). However, some 
women had no gender preference as cervical screening 
is ‘just something that happens’ (P7) and one participant 
thought that ‘once you have a few kids, you’re over it’ 
(P4).
Improving CSt awareness and participation
Cost and accessibility
A lack of bulk- billed services in regional areas was identi-
fied by women as a key barrier to cervical screening partic-
ipation. The cost of cervical screening was a ‘deterrent’ 
(P5) for attending the general practitioner for screening, 
especially in low socioeconomic women as ‘their priority 
is probably not money for them, it’s going to be feeding 
their children’ (P5). Participants also emphasised that 
cervical screening is not bulk- billed, unlike breast and 
bowel cancer. Women expressed the need for increased 
accessibility of cervical screening, especially in regional 
communities. It was suggested that cervical screening 
should have ‘pop- up’ (P9) clinics, as seen with blood 
donation and breast screening.
Media campaigns
The role of a media campaign to potentially increase 
cervical screening awareness was discussed by partici-
pants. Participants proposed that television advertise-
ments should be aired to encourage discussion about 
screening. Social media was deemed to be a valuable 
platform to educate women about cervical screening 
due to its ‘really big role in young women’s lives’ (P9) 
and the interaction remained ‘private’ (P2). Women also 
suggested that an ambassador should lead the discussion 
on cervical cancer, such as in England when a celebrity 
‘found out on Big Brother that she had cervical cancer’ 
(P3). Participants expressed that it is important to hear 
personal stories from survivors as it provides a ‘scare 
factor’ (P8) and would encourage screening.
Education programs
Participants explained the importance of education to 
improve screening participation, especially though sex 
education in schools to ensure young women have the 
‘right information’ (P5) about HPV and cervical cancer. 
Education programmes should inform women about the 
purpose of the Gardasil vaccine, the NCSP and symptoms 
of cervical cancer. Participants believed that education 
will reduce any fears related to screening and solidify ‘how 
important it is’ (P12). It was also suggested that education 
sessions should also occur at universities, playgroups and 
the workplace.
General practitioner
Participants emphasised the importance of their general 
practitioner as a trusted source of information about 
cervical screening as ‘you listen to them’ (P6). It was indi-
cated that general practitioners should facilitate oppor-
tunistic discussions about screening, especially when 
a woman turned 25 years old. Practices should display 
information in the waiting rooms and provide written 
information such as pamphlets or fact sheets, with this 
information being ‘very direct, black and white’ (P1) to 
increase the likelihood that a woman will read it. It was 
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also proposed that general practices should provide infor-
mation by phone or email.
DISCuSSIOn
It became apparent that women were hesitant about the 
new NCSP, as they were apprehensive that screening will 
miss cancers due to primary HPV testing and increased 
screening intervals. A Canadian study by Ogilvie et al 
stated that primary HPV testing was acceptable, though 
acceptability decreased when combined with increased 
screening intervals.15 Participants’ objections towards the 
change in screening may be due to the general public’s 
fatalistic view of cancer and belief that frequent testing 
leads to earlier diagnosis.16 A qualitative Irish study high-
lighted that even when women understood HPV causes 
cancer, they were anxious about screening changes due to 
their attachment to traditional pap smears.17 Participants 
were afraid that the new programme would endanger 
young women as they were perceived to be at increased 
risk of cervical cancer. This was due to participant 
concerns that young women are becoming sexually active 
earlier and queries over the effectiveness of the Gardasil 
vaccine. In reality however, women over 50 years are at 
higher risk for cervical cancer and this misconception of 
age- related risk may indicate the need for more patient 
education.18 Moreover, the new screening programme 
is predicted to have a greater impact in cervical cancer 
mortality in unvaccinated cohorts (36%) over vaccinated 
cohorts (29%).19
It is noteworthy that participants became more 
accepting of primary HPV screening after they were 
provided additional information explaining the new 
NCSP. This is congruent with Waller et al20 who described 
that women’s anxieties surrounding HPV reduced as 
health literacy increased. Participants suggested a variety 
of methods to improve screening including education 
programmes concentrating on young women. Minimal 
education occurs about cervical cancer and HPV in 
schools. Parents may pereceive it is not their responsi-
bility to educate their children on this topic, though a 
school- based education programme was an acceptable 
solution to this.21 Media and social media campaigns were 
proposed to increase awareness. Participants suggested 
the use of cancer survivors as ambassadors, though past 
research has suggested an emphasis on information from 
organisations over personal anecdotes.22 The general 
practitioner is a trusted and valued source of informa-
tion and should provide interventional health education 
with eligible women.23 24 A systematic literature review 
explains that patient’s likelihood to participate in preven-
tive screening is linked directly to the quality of discus-
sion between clinician and patient, with an emphasis on 
shared decision making rather than a simple recommen-
dation.25 More research should occur in general practice 
to develop and evaluate interventions in an Australian 
context in order to improve cervical screening.
Finally, logistical concerns prevented women from 
participating in screening. Previous literature demon-
strates that reducing economic and geographic barriers 
improve disadvantaged women’s likelihood to partici-
pate in cervical screening.26 Unlike other government 
mandated screening programmes, such as bowel and 
breast screening, women bear the burden of cost for 
cervical screening when attending their appointment 
with their general practitioner. Government policymakers 
should reassess the costs involved in cervical screening 
and consider expanding the availability of bulk- billed 
services.
Screening participation is influenced by personal and 
practitioner factors. A woman’s personal factors include: 
to be healthy, to be there for family, history of abnormal 
smears or cancer. A woman’s comfort in her relationship 
with her practitioner influenced her screening behaviour. 
This was determined by trust in her regular doctor, gender 
preference and a general feeling of comfort. A previous 
qualitative literature review similarly discussed that 
screening provides reassurance of health. Though unlike 
this study, it also iterated that the emotional response 
elicited by the test and previous negative experiences 
hindered participation.27 This may be as the literature 
review encompassed studies that included under- screened 
populations, while this study only included two under- 
screened women.
This study provides timely qualitative research on partic-
ipant’s perceptions of the new NCSP and will provide 
valuable data on these changes. Researchers conducted 
interviews using a piloted interview template until theo-
retical data saturation. It was also conducted in parallel 
to a quantitative study as an explanatory component and 
allowed for data triangulation. However, sampling at one 
private regional general practice may have led to a skewed 
representation of the population and may not include 
high- risk groups for cervical cancer. In addition, snow-
ball sampling may have led to women with more positive 
health- seeking behaviours to participate in this project. 
The use of the interpretivist paradigm may allow for 
the impact of the primary researcher bias (AN) though, 
this was minimised by a second author (JB) validating 
thematic analysis.
COnCluSIOn
Women are apprehensive about the new changes to 
the NCSP, as they believe that increased screening 
intervals and primary HPV testing may lead to missed 
cervical cancers. Personal and practitioner factors affect 
screening participation, with emphasis on maintaining 
good health and feeling ‘comfortable’ with their doctor. 
Cervical cancer participation could be improved by 
increasing education about cervical cancer and the new 
NCSP through schools, advertising campaigns and the 
general practitioner. It was also emphasised that the cost 
and accessibility of screening should be revised.
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